Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 4:9:1072239.
doi: 10.3389/fmolb.2022.1072239. eCollection 2022.

Editorial: Bioengineered nanoparticles in cancer therapy, Volume II

Payam Zarrintaj  1 , Masoud Mozafari  2 , Tomy J Gutiérrez  3 , Mohammad Reza Saeb  4
Affiliations
Editorial

Editorial: Bioengineered nanoparticles in cancer therapy, Volume II

Payam Zarrintaj et al. Front Mol Biosci. .
No abstract available

Keywords: bioengineering; biomaterials; cancer therapy; nanoparticles; nanotechnology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Volume II: Bioengineered nanoparticles in cancer therapy

References

    1. Chandraker S. K., Lal M., Khanam F., Dhruve P., Singh R. P., Shukla R. (2022). Therapeutic potential of biogenic and optimized silver nanoparticles using Rubia cordifolia L. leaf extract. Sci. Rep. 12, 8831. 10.1038/s41598-022-12878-y - DOI - PMC - PubMed
    1. Peer D., Karp J. M., Hong S., Farokhzad O. C., Margalit R., Langer R. (2020). “Nanocarriers as an emerging platform for cancer therapy,” in Nano-enabled medical applications, ed. Balogh Lajos P. (New York: Jenny Stanford Publishing, Temasek Avenue), 61–91. Available at: https://www.taylorfrancis.com/chapters/edit/10.1201/9780429399039-2/nano.... - DOI
    1. Shi J., Kantoff P. W., Wooster R., Farokhzad O. C. (2017). Cancer nanomedicine: Progress, challenges and opportunities. Nat. Rev. Cancer 17, 20–37. 10.1038/nrc.2016.108 - DOI - PMC - PubMed
    1. Weiss F., Lauffenburger D., Friedl P. (2022). Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. Nat. Rev. Cancer 22, 157–173. 10.1038/s41568-021-00427-0 - DOI - PMC - PubMed
    1. World Health Organization (WHO) (2021). The top 10 causes of death. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.

Publication types

LinkOut - more resources